糖尿病神经病变与全髋关节置换术后骨科及内科并发症增加相关
基于2005至2022年全国数据库的回顾性队列研究,比较无糖尿病、无神经病变的糖尿病及糖尿病神经病变患者行初次全髋关节置换术后的结局。倾向评分匹配后,糖尿病神经病变与术后关节感染、假体并发症及翻修风险升高相关,且90天内肺炎和伤口裂开风险增加,而无神经病变的糖尿病未见骨科风险升高。
要点
- 糖尿病神经病变患者THA术后2年假体关节感染、假体失败及翻修风险显著高于无神经病变的糖尿病患者。
- 糖尿病神经病变患者90天内肺炎和伤口裂开风险高于糖尿病及非糖尿病对照组。
- 无神经病变的糖尿病患者THA术后骨科并发症风险与非糖尿病患者无显著差异。
核心结论
- 糖尿病神经病变是全髋关节置换术后骨科并发症的独立危险因素,即使调整血糖控制和合并症负担后仍显著。
- 研究支持将神经病变评估纳入术前风险分层和围手术期管理。
研究设计与样本
- 回顾性队列研究,使用2005至2022年大型全国数据库。
- 纳入193,483例初次全髋关节置换术成人患者,分为非糖尿病组151,427例、无神经病变糖尿病组31,915例和糖尿病神经病变组10,141例。
- 采用1:1倾向评分匹配控制年龄、性别、合并症负担和糖化血红蛋白。
主要发现
- 匹配后,糖尿病神经病变组相比无神经病变糖尿病组,术后关节感染风险RR 1.57(95%CI 1.34-1.84),假体并发症风险RR 1.54(95%CI 1.34-1.78),翻修手术风险RR 1.21(95%CI 1.01-1.43)。
- 糖尿病神经病变组90天内肺炎和伤口裂开风险高于无神经病变糖尿病组和非糖尿病组。
- 无神经病变糖尿病组相比非糖尿病组,骨科并发症风险未见升高。
临床怎么用
- 术前应评估糖尿病患者是否存在周围神经病变,以识别THA术后高风险人群。
- 对合并糖尿病神经病变的患者,围手术期应加强感染预防、伤口护理和肺部并发症监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes affects over 38 million people in the United States, and diabetic neuropathy (DN) is a common complication associated with adverse musculoskeletal and vascular effects. Despite its prevalence, the impact of DN on outcomes following total hip arthroplasty (THA) remains poorly defined. This study evaluated the effect of DN on postoperative outcomes after THA compared with nondiabetic patients and patients who had diabetes without neuropathy. METHODS: A retrospective cohort study was conducted using a large national database in the years 2005 to 2022. Adults undergoing primary THA were categorized into three groups: nondiabetic patients, patients who have diabetes without neuropathy (diabetes mellitus [DM]), and patients who have DN. Outcomes included 2-year orthopaedic complications, including periprosthetic joint infection, implant failure, periprosthetic fracture, and revision; and 90-day medical complications. Propensity score matching (1:1) controlled for age, sex, comorbidity burden, and hemoglobin A1c. The study cohort consisted of 193,483 patients: 151,427 nondiabetic patients, 31,915 patients who have diabetes without neuropathy, and 10,141 patients who have DN. RESULTS: After matching, compared with DM, DN was associated with higher risks of postoperative joint infection (relative risk [RR] 1.57, 95% confidence interval [CI] 1.34 to 1.84), implant complications (RR 1.54, 95% CI 1.34 to 1.78), and revision surgery (RR 1.21, 95% CI 1.01 to 1.43). Patients who had DN also demonstrated increased 90-day risks of pneumonia and wound disruption compared with both DM and nondiabetic cohorts. In contrast, DM showed no increased orthopaedic risk compared with nondiabetic patients. CONCLUSIONS: Diabetic neuropathy was independently associated with increased orthopaedic complications following THA, even after adjusting for glycemic control and comorbidity burden. These findings identify DN as an important driver of postoperative risk and support incorporating neuropathy assessment into preoperative risk stratification. These findings support incorporating neuropathy assessment into preoperative risk stratification and perioperative management.
引用
- Kotzur T, VanderWeele BP, Barnes M, et al. Diabetic Neuropathy Is Associated With Increased Orthopaedic and Medical Complications After Total Hip Arthroplasty. J Arthroplasty. 2026. PMID: 42520991. doi:10.1016/j.arth.2026.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。